The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lungs of Nonhuman Primates
Abstract
To define the toxicity of cystic fibrosis transmembrane conductance regulator gene (CFTR) gene therapy with a replication-deficient recombinant adenovirus (Av1Cf2) in a nonhuman primate model, 10(10) plaque forming units (pfu) were instilled directly through a bronchoscope into the right lung of 5 macaques, and a lower dose of 4 x 10(6) pfu was administered to the right lung of 1 macaque. One sham-treated control received phosphate-buffered saline (PBS). The macaques were evaluated sequentially by clinical examination, vital signs, weight, hematology, blood chemistry, chest radiography, pulse oximetry, and bronchoalveolar lavage (BAL) at baseline and 3-28 days post-treatment. After the period of observation, macaques were sacrificed for autopsy and histological examination. The macaques tolerated the experimental therapy clinically with no changes in body temperature, oxygen saturation, heart rate, body weight, or blood pressure. However, 1 macaque with visible evidence of aspiration at the time of initial bronchoscopy developed tachypnea with right lower lobe (RLL) pneumonia on chest radiograph and by histology. There were no changes in Hgb, Wbc, BUN, plasma electrolytes, bilirubin, or hepatic transaminases. In the macaques that received 10(10) pfu, there was a progressive increase in the number of CD8+ lymphocytes in BAL that was maximal at 28 days. Histological examination of the treated lungs of the high-dose macaques at 3 days showed marked peribronchial and perivascular…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First generation recombinant AdV vectors are devoid of viral gene E1 [30]. These vectors cause an acute as well as chronic immune response.”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [30]
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,253
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution
Rennard, S. I., Basset, G., Lecossier, D., O'Donnell, K. M., Pinkston, P., Martin, P. G., & Crystal, R. G. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.60.2.532 · Cited by 1,131
Bear, C. E., Li, C., Kartner, N., Bridges, R. J., Jensen, T. J., Ramjeesingh, M., & Riordan, J. R. (1992) · Cell · doi:10.1016/0092-8674(92)90155-6 · Cited by 945
Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90213-v · Cited by 931
Self-citationCrystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 826
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
Caplen, N. J., Alton, E. W. F. W., Mddleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S. R., Jeffery, P. K., Hodson, M. E., Coutelle, C., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-39 · Cited by 711
Rich, D. P., Anderson, M. P., Gregory, R. J., Cheng, S. H., Paul, S., Jefferson, D. M., McCann, J. D., Klinger, K. W., Smith, A. E., & Welsh, M. J. (1990) · Nature · doi:10.1038/347358a0 · Cited by 708
Zabner, J., Couture, L. A., Gregory, R. J., Graham, S. M., Smith, A. E., & Welsh, M. J. (1993) · Cell · doi:10.1016/0092-8674(93)80063-k · Cited by 681
Yang, Y., Ertl, H. C. J., & Wilson, J. M. (1994) · Immunity · doi:10.1016/1074-7613(94)90074-4 · Cited by 611
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer
Drumm, M. L., Pope, H. A., Cliff, W. H., Rommens, J. M., Marvin, S. A., Tsui, L.-C., Collins, F. S., Frizzell, R. A., & Wilson, J. M. (1990) · Cell · doi:10.1016/0092-8674(90)90398-x · Cited by 576
Interleukin-8 (IL-8): The Major Neutrophil Chemotactic Factor in the Lung
Kunkel, S. L., Standiford, T., Kasahara, K., & Strieter, R. M. (1991) · Experimental Lung Research · doi:10.3109/01902149109063278 · Cited by 553
Engelhardt, J. F., Ye, X., Doranz, B., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6196 · Cited by 470
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis
Johnson, L. G., Olsen, J. C., Sarkadi, B., Moore, K. L., Swanstrom, R., & Boucher, R. C. (1992) · Nature Genetics · doi:10.1038/ng0992-21 · Cited by 439
Alton, E. W. F. W., Middleton, P. G., Caplen, N. J., Smith, S. N., Steel, D. M., Munkonge, F. M., Jeffery, P. K., Geddes, D. M., Hart, S. L., Williamson, R., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-135 · Cited by 402
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.
Ginsberg, H. S., Moldawer, L. L., Sehgal, P. B., Redington, M., Kilian, P. L., Chanock, R. M., & Prince, G. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1651 · Cited by 353
Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Toxicity Study
Simon, R. H., Engelhardt, J. F., Yang, Y., Zepeda, M., Weber-Pendleton, S., Grossman, M., & Wilson, J. M. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-771 · Cited by 323
Zabner, J., Petersen, D. M., Puga, A. P., Graham, S. M., Couture, L. A., Keyes, L. D., Lukason, M. J., St. George, J. A., Gregory, R. J., Smith, A. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0194-75 · Cited by 212
Fick, R. B., Naegel, G. P., Squier, S. U., Wood, R. E., Gee, J. B., & Reynolds, H. Y. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111407 · Cited by 201
Nagaoka, I., Trapnell, B. C., & Crystal, R. G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114669 · Cited by 181
Self-citationYoshimura, K., Nakamura, H., Trapnell, B. C., Dalemans, W., Pavirani, A., Lecocq, J. P., & Crystal, R. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31562-x · Cited by 177
Self-citationYei, S., Mittereder, N., Wert, S., Whitsett, J. A., Wilmott, R. W., & Trapnell, B. C. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.6-731 · Cited by 172
Self-citationHirsch, R., Eckhaus, M., Auchincloss, H., Sachs, D. H., & Bluestone, J. A. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.11.3766 · Cited by 167
Self-citationDevelopment and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis
Rich, D. P., Couture, L. A., Cardoza, L. M., Guiggio, V. M., Armentano, D., Espino, P. C., Hehir, K., Welsh, M. J., Smith, A. E., & Gregory, R. J. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-461 · Cited by 162
Zsengellér, Z. K., Wert, S. E., Hull, W. M., Hu, X., Yei, S., Trapnell, B. C., & Whitsett, J. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.4-457 · Cited by 147
Self-citationBrody, S. L., Metzger, M. E., Danel, C. J., Rosenfeld, M. A., & Crystal, R. G. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.7-821 · Cited by 142
Chu, C. S., Trapnell, B. C., Curristin, S. M., Cutting, G. R., & Crystal, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115952 · Cited by 123
Self-citationBoucher, R. C., Knowles, M. R., Johnson, L. G., Olsen, J. C., Pickles, R. J., Wilson, J. M., Engelhardt, J. F., Yang, Y., & S, M. G. B. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.5-615 · Cited by 118
Wilson, J. M., Engelhardt, J. F., S, M. G. B., Simon, R. H., & Yang, Y. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.4-501 · Cited by 90
Role of early genes in pathogenesis of adenovirus pneumonia.
Ginsberg, H. S., Horswood, R. L., Chanock, R. M., & Prince, G. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6191 · Cited by 79
Whitsett, J. A., Dey, C. R., Stripp, B. R., Wikenheiser‐Brokamp, K. A., Clark, J. C., Wert, S. E., Gregory, R. J., Smith, A. E., Cohn, J. A., Wilson, J. M., et al. (1992) · Nature Genetics · doi:10.1038/ng0992-13 · Cited by 77
Self-citationMittereder, N., Yei, S., Bachurski, C. J., Cuppoletti, J., Whitsett, J. A., Tolstoshev, P., & Trapnell, B. C. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.6-717 · Cited by 74
Self-citationSorscher, E. J., Logan, J. J., Frizzell, R. A., Lyrene, R. K., Bebok, Z. M., Dong, J., DuVall, M. D., Feigner, P. L., Matalon, S., Walker, L., et al. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.10-1259 · Cited by 67
Amin, R. S., Wilmott, R. W., Schwarz, Y., Trapnell, B. C., & Stark, J. M. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.2-145 · Cited by 64
Self-citationWelsh, M. J., Smith, A. E., Zabner, J., Rich, D. P., Graham, S. M., Gregory, R. J., Pratt, B. M., & Moscicki, R. A. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.2-209 · Cited by 58
Prospects for virus-based gene therapy for cystic fibrosis
Flotte, T. R. (1993) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00768066 · Cited by 34
Recent Advances in the Treatment of Cystic Fibrosis
Wilmott, R. W., & Fiedler, M. A. (1994) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38764-8 · Cited by 30
Self-citationBayle, J.-Y., Johnson, L. G., George, J. A. S., Boucher, R. C., & Olsen, J. C. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.2-161 · Cited by 27
(1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.8-1019 · Cited by 17
Gene therapy for pulmonary diseases.
Rosenfeld, M. A., Ronald, G. C., & Crystal, R. G. (1993) · PubMed · Cited by 13
Haemophiliacs seek compensation
Moran, N. (1995) · Nature Medicine · doi:10.1038/nm0195-6 · Cited by 12
Research works printed but not linked: 8
- CRYSTAL R.G., 1993, Am. Rev. Respir. Dis., 147, A544
- CRYSTAL R.G., 1992, Fed. Reg., 57, 49584
- ROSENFELD M.A., 1993, Pathol. Biol., 41, 677
- 10.1089/hum.1993.4.6-771 · DOI · Paper page
- TRAPNELL B.C., 1993, Pediatr. Pulmonol. S., 9, 241
- J., 1992, Fed. Reg., 57, 49584
- BOAT T.F., 1976, Am. Rev. Respir. Dis., 113, 833
- YEI S., 1994, Pediatr. Pulmonol. (Suppl.), 10, 151
Cited by
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
Mittereder, N., March, K. L., & Trapnell, B. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7498-7509.1996 · Cited by 777
Self-citationParks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., & Graham, F. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13565 · Cited by 725
Schnell, M. A., Zhang, Y., Tazelaar, J., Gao, G.-P., Yu, Q. C., Qian, R., Chen, S.-J., Varnavski, A. N., LeClair, C., Raper, S. E., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0330 · Cited by 342
Konstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H., Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1255 · Cited by 298
Viral Delivery Systems for CRISPR
Xu, C. L., Ruan, M. Z. C., Mahajan, V. B., & Tsang, S. H. (2019) · Viruses · doi:10.3390/v11010028 · Cited by 277
Metadata
- Authors
- Wilmott, R. W., Amin, R. S., Perez, C. R., Wert, S. E., Keller, G., Boivin, G. P., Hirsch, R., de Inocencio, J., Lu, P., Reising, S. F., Yei, S., Whitsett, J. A., & Trapnell, B. C.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1996-02-10
- Volume
- 7
- Issue
- 3
- Pages
- 301-318
- ISSN
- 1043-0342
- 1557-7422
- Cited by
- 63
- References
- 42
- Language
- en
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.